Evidence supports cannabis-based therapies for a limited number of conditions. Here’'s what clinicians should know — and tell ...

A new study suggests that a specially developed medicine containing compounds derived from cannabis may help people with ...

The second phase of LiBBY Trial has indicated that cannabis-driven treatment could help alleviate symptoms of agitation in ...

A combination of THC and CBD eased symptoms in an especially frail population: patients with advanced dementia near the end ...

Initial Medical Cannabis SKUs, Including Rapid-Onset Capsules and Soft Chews, Planned for Q3 2026 Improving Patient Access ...

Treatment for cannabis use disorder (CUD) decreased since 2004, particularly in states with medical cannabis dispensary provisions, according to a new study at Columbia University Mailman School of ...

As cannabis becomes more potent and widely used in the United States—especially among young adults—concerns about cannabis use disorder are growing. More than 16 million Americans meet the criteria, ...

A study published in Cannabis and Cannabinoid Research examined the effects of medical cannabis on patients diagnosed with ...

Forbes contributors publish independent expert analyses and insights. Dario Sabaghi covers the cannabis industry with a focus on Europe. A new study has found that the legalization of cannabis is not ...

New research challenges the policy of some opioid use disorder (OUD) treatment programs that require patients to abstain from cannabis before qualifying for treatment. Pooled data from 10 longitudinal ...

As cannabis becomes more potent and widely used in the United States – especially among young adults – concerns about cannabis use disorder are growing. More than 16 million Americans meet the ...

Admission Delays in Receiving Treatment for Cannabis Use Disorder among US Adolescents was published April 2026 in the American Journal of Preventive Medicine. "I hope this research draws attention to ...